Conclusion: The findings indicate the emerging Bartonella exists in animal and human in China mainland. This needs further assessment for public awareness and preparedness. The development and implementation of specific and sensitive diagnostic assays is urgently required for establishing a state surveillance and diagnostic capacity by the reference diagnostic laboratories. Further studies will be needed to establish the specific genotype of the Chinese isolates, and to understand their reservoir association, mode of transmission, spectrum of diseases, and pathological conditions they may cause in mammals. Current knowledge on Bartonella species and bartonelloses found in mainland China and their role as causes of febrile illness in China are presented as guides for local physicians in China and for travel medicine physicians and tourists abroad. The recent SARS epidemic in 2003 has boosted interests in discovery of novel coronaviruses in both humans and animals. Two novel human coronaviruses, human coronavirus NL63, a novel group 1 human coronavirus; and human coronavirus HKU1, a novel group 2 human coronavirus; were reported in 2004 and 2005 respectively. As for animal coronaviruses, we and others have described the discovery of SARS-CoV-like viruses in horseshoe bats in Hong Kong and other provinces of China. In addition, numerous other novel coronaviruses in bats as well as other animals, such as giraffe, turkey and beluga whale, have been discovered. These discoveries and comparative genomics studies have led to proposal of novel subgroups of coronaviruses. Recently, we have also developed a comprehensive database, CoVDB (http://covdb.microbiology.hku.hk), of annotated coronavirus genes and genomes, for rapid and accurate batch sequence retrieval, the cornerstone and bottleneck for comparative gene or genome analysis. With these, we will be able to get a more in-depth understanding on coronavirus phylogeny.
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The interaction between M1 protein of influenza virus and host cell factors X.L. Liu, W.J. Liu *. Center for Molecular Virology, Department of pathogenic Microbiology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China Influenza A virus matrix protein (M1) is the most abundant protein in the viral particle, consisting of highly conserved 252-amino acids. M1 is a multifunctional protein in the influenza virus replication. Several host cell factors have been identified possibly to be required for regulation of influenza virus replication through interacting with M1. The knowledge obtained from these virus-host cell interactions are continuing provide critical insights into the molecular mechanisms of the biology and pathology of the virus. In our study the yeast two-hybrid system was performed using M1 as the bait to search for possible counterpart host proteins. Several candidate proteins have been identified including cyclophilin A (CypA), specifically interacting with M1. We have demonstrated that CypA was able to directly bind to the M1 protein. The functional analysis indicated that CypA regulated the influenza virus replication. The recent emergence of highly pathogenic avian influenza A virus strains with subtype H5N1 pose a global threat to human health. Elucidation of the underlying mechanisms of viral replication is critical for development of anti-influenza virus drugs. The influenza RNA-dependent RNA polymerase (RdRp) heterotrimer, containing PA, PB1 and PB2, plays crucial roles in viral RNA replication and transcription. PB1 is known to harbour polymerase activities and PB2 is responsible for cap binding. PA is implicated involving in RNA replication, endonuclease and proteolytic activity, however, its functional mechanism remains elusive. Recently, we have determined the crystal structures of avian H5N1 influenza A virus PA protein. The structures of PA have provided detail information for the binding of PB1 to PA and implicated its previously unknown functional mechanisms. Our structure also reveals that PA is a significant target for novel antiinfluenza therapeutics.
